Lionbridge Technologies, Inc. (LIOX): Glenhill Advisors Further Reduces Its Holding

In a filing with the SEC, Glenn J. Krevlin‘s Glenhill Advisors has revealed further reducing its stake Lionbridge Technologies, Inc. (NASDAQ:LIOX). Glenhill has sold around 1.11 million shares of the language and content testing solutions company in three transactions, at an average price of $5.88. Following the disposal of securities, Glenhill still owns around 5.82 million shares of the company.

Lionbridge Technologies, Inc. (NASDAQ:LIOX)

Glenhill has significantly cut its exposure to Lionbridge Technologies, Inc. (NASDAQ:LIOX), taking into account that the investor held over 9.4 million shares as of the end of the first quarter of the year. Aside from Glenhill Advisors, another shareholder of Lionbridge Technologies, Inc. (NASDAQ:LIOX)  is Phil Frohlich‘s Prescott Group Capital Management, which added around 36,000 shares of the company during the second quarter, currently holding close to 216,900 shares. Renaissance Technologies, led by Jim Simons, owned 809,500 shares of Lionbridge Technologies, Inc. (NASDAQ:LIOX), as of the end of the March, the stake being upped by 50% over the quarter.

Disclosure: none

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!